Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-06

Clinical Trial Update: Seroquel Long-Term NIS for Schizophrenia Patients

View source ↗

Summary

Completion of a long-term non-interventional study of quetiapine (Seroquel) in patients with schizophrenia and schizoaffective disorder has been reported. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED